Decorin belongs to the small leucinerich repeat proteoglycan family, interacts with fibrillar collagens, and regulates the assembly, structure and biomechanical properties of connective tissues. The decorincollagen type I binding region is located in leucine-rich repeats 5-6. Site-directed mutagenesis of this 54 residues long collagenbinding sequence identifies Arg207 and Asp210 in leucine-rich repeat 6 as crucial for the binding to collagen. The synthetic peptide SYIRIADTNIT, which includes Arg207 and Asp210, inhibits the binding of full-length recombinant decorin to collagen in vitro. These collagen-binding amino acids are exposed on the exterior of the β-sheet -loop structure of the leucine-rich repeat. This resembles the location of interacting residues in other leucine-rich repeat proteins.
Decorin is an extracellular matrix proteoglycan involved in collagen type I fibril formation and collagen matrix assembly in a wide range of connective tissues (1) (2) (3) . Decorin belongs to the small leucine-rich repeat proteoglycan family (SLRPs) 1 (4) , which also includes e.g. biglycan (5), fibromodulin (6) , lumican (7) , and asporin (8, 9) . The decorin core protein is composed of 12 tandem leucine-rich repeats (LRRs), each containing an average of 24 amino acid residues. The decorin threedimensional structure, resolved by X-ray crystallography, reveals an arch-shaped molecule with LRRs composed of parallel betasheets on the concave surface, and short β-strands, 3 10 helices and polyproline II helices on the convex face (10) . Close to the N-terminus, decorin is substituted with a single chondroitin or dermatan sulfate chain. Decorin also has three potential consensus sites for N-glycosylation in the LRR domain (4) .
Several SLRPs are involved in the regulation of collagen fibril formation and matrix assembly, as demonstrated in SLRPdeficient mice (11) . Decorin deficiency causes skin fragility (12) ; biglycan-deficient mice suffer from reduced bone mass and osteoarthritis (13) ; lack of fibromodulin results in weaker tendons and ligaments, causing osteoarthritis (14) ; and lumican ablation correlates with corneal opacity (15) . In all these cases, ultra-structural imaging reveals abnormally developed collagen fibrils.
Decorin presumably affects the lateral association of collagen type I fibrils in vitro, as it binds to collagen monomers and delays their accretion to the growing fibrils (1) . Collagen fibrils in skin of decorin-deficient mice are thicker and irregularly shaped, in contrast to smaller, uniform fibrils formed in wild type mice (12) . Decorin binds near the C terminus of collagen, close to an intermolecular crosslinking site (16) and seems to have a tutelary function in collagen fibril assembly, which is important for the collagen cross-linking. In addition, decorin also binds collagen type VI (17) , TGF-β (18), fibronectin (19) , and EGF receptor (20) .
The precise decorin binding site for collagen has not been determined. An early study identified two collagen-binding sites in decorin (21) . A later report assigned a collagenbinding site to and Glu180 in decorin LRR 5 (Glu180 in human decorin corresponds to Glu181 in the bovine sequence) was proposed to be essential for the interaction (23) . Decorin with a E180Q mutation was later demonstrated to bind stronger to collagen type VI than wild type decorin and amino acid residues located C-terminal of Gln153 in decorin were implicated in the collagen binding (24) . In addition to the core protein, also the dermatan sulfate chain has been reported to be involved in the collagen interaction (25) . This glycosaminoglycan-collagen interaction is weaker than the core protein-collagen interactions (22) (23) (24) .
It is of interest to characterize this prototype decorin-collagen interaction, since also other SLRPs, e.g. fibromodulin and lumican, interact with fibrillar collagens and affect connective tissue properties in similar ways. The concerted action of several SLRPs can determine the structure and function of collagen matrices. In this study, we used sitedirected mutagenesis of decorin LRR 5-6 to clarify the location of the collagen-binding site.
Experimental procedures
Expression of GST-tagged bacDCN56 in bacteria -Bovine decorin cDNA (GenBank Accession Number NM_173906) was used as a template in PCR, to amplify cDNA encoding LRR 5-6 of decorin. The primers used for the PCR were: 5'-AAAGGATCCAACGAGATCACCAAAGTGC G-3' and 5'-AAACCCGGGTATATTTGTGTCAGCAATG CG-3'. The amplified cDNA was digested with the restriction enzymes BamHI and SmaI, and ligated into the vector pGEX-4T-3 (Amersham Biosciences, Sweden). The construct was sequenced to confirm the identity, transfected into BL21 E. coli, and bacDCN56 protein was expressed according to the manufacturer's instruction. bacDCN56 was purified under native conditions by glutathione-affinity chromatography, as previously described (26) and dialysed against PBS with 0.2% (v/v) Tween-20 prior to use. The protein concentration was determined with Coomassie Protein Assay Reagent (Pierce, USA). Expression of his-tagged fibromodulin in bacteria -Bovine fibromodulin cDNA (GenBank Accession Number X16485) was used as a template in PCR, to amplify fibromodulin cDNA. The primers used for the PCR were: 5'-CCGGATCCCCAATATGAGGAAGACTCTC AC-3' and 5'-CCCTCGAGGATCTCGATGAGGCTAGCC-3'. The amplified cDNA was digested with XhoI and BamHI restriction enzymes, ligated into a pET-27b(+) expression vector (Novagen, USA), and the his-tagged protein was expressed in Rosetta cells (Novagen, USA). Fibromodulin was purified using Ni-NTA agarose (Qiagen, Germany) according to the manufacturer's instruction. Prior to use, the protein was dialyzed against PBS with 0.2% (v/v) Tween-20. Site-directed mutagenesis -bacDCN56 cDNA and bovine decorin cDNA (GenBank Accession Number NM_173906) were used for sitedirected mutagenesis using QuikChange II kit and pBluescript® II KS (+/-) cloning vector (both from Stratagene, Sweden) according to the manufacturer's instruction. Mutations of bacDCN56, used in bacterial protein expression, were the following: E162Q, E181K, E181Q, T184V, E193Q, Y205F, R207S, D210N. Mutations of bovine decorin, used for mammalian cell protein expression, were: E181K, R207S, and D210N. Primers used for mutagenesis are listed in Supplemental Figure 1 . Mammalian expression of wild type decorin and mutated decorins -Wild type or mutated decorin cDNA was digested with the restriction enzymes HindIII and BamHI, and ligated into the pCEP4 BM40-hisEK expression vector (27) , attaching the decorin cDNA to his-tag DNA in the N-terminus. The constructs were sequenced to confirm identity and transfected into human embryonic kidney 293 cells by electroporation, as described (22) . Cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% (v/v) fetal calf serum (Invitrogen, Sweden). After 24 h, hygromycin (Invivogen, France) was added to concentration of 150 µg/mL. After one week, single clones were picked, incubated in medium containing [
35 S]-sulfate, and analyzed for proteoglycan expression, as described (22) . The proteoglycanexpressing clones were cultured in EX-Cell 325 PF CHO protein-free medium (JRH Biosciences, USA) for 12 days with four medium changes every three days. The medium was dialyzed against 300 mM NaCl and 20 mM NaH 2 PO 4 buffer (pH 8.0), and proteoglycans were purified using Ni-NTA agarose (Qiagen, Germany), and eluted with 250 mM imidazole in 300 mM NaCl and 20 mM NaH 2 PO 4 buffer (pH 8.0). Peptide synthesis-Peptides SYIRIADTNIT and SYISIANTNIT were purchased from Schafer-N (Denmark) and dissolved in PBS with 0.2% (v/v) Tween-20. Solution-phase collagen-binding assayCollagen-binding assays were performed by incubation of 15 µg of acetic acid-extracted mouse tail collagen in 100 µl PBS pH 7.4 with addition of different concentrations of radiolabeled decorin, as previously described (17) . Neutralization of acid solubilised collagen leads to the formation of collagen fibrils, which bind decorin. After incubation for 5 h at 37°C, samples were centrifuged for 5 min at 13 000 x g to separate collagen fibrils with bound decorin in the pellet from non-bound decorin in the supernatant. More than 90% of the collagen was recovered as fibrils in the pellet. The supernatant was removed, and the pellet was washed once with 1 ml PBS. The pellet and the supernatant were then electrophoresed on a 10% SDS-PAGE, and the amount of radiolabeled proteoglycans was determined in FLA-3000 Bio Imaging Analyzer (Fuji Photo Film Co., Japan). The data were analyzed by nonlinear regression using GraphPad Prism 3 software (GraphPad Software, Inc., USA). Solid-phase collagen-binding assay -Microtiter 96-well Maxisorp plates (Nunc, Denmark) were coated for 16 h using 10 µg/mL acetic acidextracted mouse tail collagen in acetic acid. The wells were washed with PBS and blocked for 1 h with 1 mg/mL bovine serum albumin (BSA) in PBS with 0.2% (v/v) Tween-20. After a single wash using PBS with 0.5 mg/mL BSA and 0.2% (v/v) Tween-20 (wash buffer), the GST-decorin fusion proteins were added and after three hours the wells were washed five times with the wash buffer. The amounts of GST fusion proteins bound to collagen were determined using 1-chloro-2,4-dinitrobenzene and reduced glutathione, as previously described (28). Similar procedure was followed for assays with his-tagged full-length decorin and decorin mutants, but the detection was done with rabbit anti-His-tag antibody ab9108 (Abcam, UK) diluted 1:250 in the wash buffer, and swine antirabbit alkaline phosphatase-conjugated antibody (DAKO, Denmark) diluted 1:500 in the wash buffer, and detection with phosphatase substrate p-Nitrophenyl Phosphate (Sigma, Sweden). For peptide inhibition assays, the peptide in different concentrations was added to decorin or fibromodulin prior to incubation.
Collagen fibrillogenesis assay -The assays were performed as previously described (29) . Pepsinextracted acid-solubilized collagen (Vitrogen, USA) was neutralized and diluted (167 pM) in 150 mM NaCl 20 mM HEPES, pH 7.4 with decorin or mutated decorins at 4°C. Solutions were degassed and then incubated at 37°C for 10 hours in a spectrophotometer where the absorbance was continuously recorded at 400 nm.
RESULTS
To study the interaction between decorin and collagen type I, we initially expressed decorin LRR 5-6, previously shown to bind collagen (22, 23) , as a GST-fusion protein in bacteria (bacDCN56). This fusion protein inhibited the binding of mammalian-expressed full length [ 35 S]-decorin to collagen in solution, indicating that they bind to the same site on collagen (Fig. 1) . This confirms the collagenbinding properties of bacDCN56, which was used in the further characterization of the decorin-collagen interaction. To identify the amino acid residues involved in the interaction we performed site-directed mutagenesis. We selected residues in bacDCN56 that were either conserved between species, charged or polar, and also exposed on the exterior of the protein (Fig. 2) . Thus, the mutations E162Q, E181K, E181Q, T184V, E193Q, Y205F, R207S, and D210N were introduced into bacDCN56 and expressed in E. coli. The binding of the mutated decorin fragments was determined using a solidphase binding assay. bacE162Q, bacE181K, bacE181Q, bacT184V, bacE193Q, and bacY205F showed similar binding properties as the control (non-mutated) bacDCN56. In contrast, bacR207S and bacD210N had lower affinity for collagen (Fig. 3) .
To corroborate the above results, we introduced the D210N, R207S, and E181K mutations in the full length decorin cDNA, and expressed them as his-tagged proteins in 293 cells. The collagen affinities of the mutated decorins were determined in a solution-phase collagen-binding assay, in which the collagen molecules presumably form fibrils during the incubation at 37°C. Wild type decorin has a sigmoidal binding curve (K D = 60 nM), while all mutated decorins have linear binding curves indicating non-specific binding (Fig. 4) .
In a solid-phase assay, wild type decorin also has a sigmoidal binding curve with K D = 6 nM, while extrapolation of the linear binding curves for mutated decorins gives K D = 350 nM for mamE181K, K D = 1 mM for mamR207S, and K D = 1 mM for mamD210N (Fig. 5) .
A synthetic peptide SYIRIADTNIT, which encompasses Arg207 and Asp210 in LRR 6, was used to inhibit the binding of decorin and fibromodulin to collagen. In a solid-phase assay, the peptide inhibited the decorin-collagen interaction at K i = 4 µM, while the collagenfibromodulin interaction was unaffected. The control peptide SYISIANTNIT, with R207S and D210N mutations, did not inhibit the decorincollagen binding (Fig. 6) .
We also analysed how the mutations R207S and D210N affected the collagen fibrillogenesis in vitro. Incubation of acid solubilized collagen with decorin at neutral pH and 37 o C leads to a slower collagen fibril formation and a lower final turbidity (1). 2 µg/ml decorin completely inhibited and 1 µg/ml inhibited the formation of fibrils by approximately 50% (Fig. 7) . Incubation of collagen in the presence of mamD210N at 2 and 1 µg/ml affected the fibrillogenesis only marginally. mamR207S at 2 µg/ml resulted in approximately 50% inhibition of fibrillogenesis. Also the peptide SYIRIADTNIT at 150 µg/ml lowered the turbidity significantly whereas the control peptide at the same concentration had no effect.
DISCUSSION
We show that decorin LRR 5-6 domain, encompassing Arg207 and Asp210, is of importance for collagen binding. Mutations of these two amino acid residues impaired binding to reconstituted collagen fibrils in solution and monomeric collagen adsorbed on plastic surface. Glu181 (Glu180 in human decorin corresponds to Glu181 in the bovine sequence) was previously reported to be essential for the collagen interaction (23) and, interestingly, the E181K and E181Q mutations expressed as GSTfusion proteins in bacteria did not impair binding to monomeric collagen-coated surfaces. However, mammalian full-length E181K decorin lost the affinity for collagen. This discrepancy may be due to structural changes induced by the E181K and E181Q mutations, rather than direct involvement of Glu181 in collagen binding. The crystal structure of decorin indicates that the side chain of Glu181 potentially forms hydrogen bonds with the side chains of Arg207 and His159 on the neighbouring LRR domains. Glu181 also forms a hydrogen bond with the peptide bond of the proximal β-sheet (10). Consequently, mutation of this glutamate residue may lead to misfolding of the protein core, and collagen-binding sites could be sterically hindered from interaction in full-length decorin. We used the program CUPSAT (30) to predict changes in protein stability upon point mutations. The E181K mutation has a destabilised structure and an unfavourable torsion, with predicted ∆∆G = -5.5 kcal/mol. Also, the R207S mutation has an unfavourable ∆∆G = -1.66 kcal/mol, which could indirectly impair collagen-binding. In contrast, the D210N mutation has ∆∆G = 0.2 kcal/mol, not affecting the structure.
The misfolding of decorin may also explain the reduction in amount of E181K-mutated decorin synthesized by 293 cells, as the protein is presumably retained in the ER and not properly secreted. After screening of several clones of 293 cells transformed with mamE181K, we could not identify clones expressing large amounts of mamE181K (data not shown). In bacE181K, only two LRRs are expressed and the collagen-binding site possibly remains exposed for interaction. The crystal structure of decorin indicates that Asp210 side chain does not form intramolecular hydrogen bonds, has a high solvent exposure (60%, according to CUPSAT analysis), and is not involved in the putative dimer formation. On the other hand, both Glu181 and Arg207 are less exposed to solvent (2% and 22% respectively), buried within the putative dimer contact surface, and have potential structure-stabilizing intramolecular hydrogen bonds. Our results indicate that Asp210 directly contributes to the collagen binding, while the Arg207 and Glu181 may have structural functions. Indeed, sequence alignment of decorin LRR 5-6 sequences in 15 species reveals conservation of these three amino acids, emphasizing their structural role and involvement in collagen-binding (Supplemental Figure 2) .
Notably, amino acid residues in other LRR proteins involved in interactions are positioned in the same region of the leucine-rich repeat as the decorin Asp210; e. g. Asp175 and Glu128 of glycoprotein Ib are critical for complex formation with von Willebrand factor (31), and Asp435 of ribonuclease inhibitor is crucial for binding RNase A and angiogenin (32) . In analogy with decorin, these charged amino acids are positioned in the β-sheet -loop region of the LRR domain, and the side chains are exposed to solvent. Similar location of binding sites can be found in other LRR proteins (33) , implying conserved binding patterns.
The peptide sequence SYIRIADTNIT is located in LRR 6 of decorin and includes the residues Arg207 and Asp210. This peptide inhibits the decorin-collagen type I interaction at K i = 4 µM. Although this makes the peptide a potent inhibitor of decorin-collagen interaction, the inhibition is not complete. This implies the existence of other, seemingly weaker, collagenbinding site in decorin and agrees with previous reports (21, 22, 24) . Also binding of mutated decorins to collagen indicates the presence of multiple binding sites in decorin (Fig. 4, 5) . The mutated decorins have linear binding curves, as opposed to sigmoidal binding curve of wild type decorin, which indicates weak or non-specific binding. Since it is conceivable that the glycosaminoglycan chain could also contribute to collagen binding, we assessed the binding of chondroitinase ABC-treated decorin in the solidphase assay and compared it with decorin proteoglycan. Both decorins had similar collagen binding, suggesting minor contribution by the glycosaminoglycan chain in collagen-binding (data not shown).
We also investigated how mutated decorins and synthetic peptides affect collagen fibrillogenesis. It has been demonstrated that decorin inhibits the rate of collagen fibril formation in vitro and reduces the turbidity of the formed fibrils (1). It is believed that decorin binds collagen and interferes with the lateral growth of fibrils. The reduction in turbidity is primarily due to the formation of thinner collagen fibrils in the presence of decorin. Our results show that decorin dramatically inhibits fibrillogenesis at a collagen:decorin molar ratio of 1:8.(collagen Mw 300 kDa and decorin Mw 100 kDa) (Fig. 7) . mamR207S also significantly inhibits fibrillogenesis at a molar ratio of 1:8, although not as efficiently as decorin. This may be explained by the collagen-binding mediated by Asp210 in mamR207S. Also. mamD210N retains some inhibition of fibril formation, which indicates additional collagen-binding sites, not involving Asp210 and Arg207. Interestingly, also the synthetic peptide SYIRIADTNIT showed inhibition of collagen fibril formation when present at high concentrations. A collagen:peptide molar ratio of 1:360 (collagen Mw 300 kDa and peptide Mw 1,3 kDa) resulted in 25% inhibition of fibril formation. The control peptide SYISIANTNIT did not interfere with the fibril formation. Apparently the synthetic peptide SYIRIADTNIT has the capacity to bind collagen and interfere with the lateral growth of fibrils.
The collagen-binding site of decorin is homologous to sequences in asporin and biglycan, which are the closest relatives of decorin and belong to the same SLRP subfamily. The decorin sequence SYIRIADTNIT is partially conserved in the asporin sequence HIRIAEAKLT, and in the biglycan sequence NYLRISEAKLT. The sequences are located in LRR 6 and their collagen-binding properties are unknown. 1 The abbreviations used are: SLRP, small leucine-rich repeat proteoglycan; LRR, leucine-rich repeat; GST, glutathione S-transferase; PCR, polymerase chain reaction; PBS, phosphate-buffered saline; histag, hexahistidine tag; Ni-NTA, nickel-nitrilotriacetic acid; DMEM, Dulbecco's modified Eagle's medium; SDS-PAGE, sodium dodecyl sulphate -polyacrylamide gel electrophoresis; BSA, bovine serum albumin; K D , constant of dissociation; K i , constant of inhibition. After centrifugation, pellets and supernatants were analyzed by SDS-PAGE, and radiolabeled decorin bound (P) and non-bound in the supernatant (S) was determined by phosphoimaging. Fig. 2 . A.Three-dimensional structure of decorin with amino acids selected for mutagenesis denoted and their side chains displayed. B. Primary sequence of bacDCN56. Arrows denote substitutions by mutagenesis and underlined amino acid residues are conserved in 15 species (see Supplemental Figure  2 ). Fig. 3 . Binding of bacDCN56 variants to collagen type I. Acetic acid-extracted collagen type I was coated on plastic and incubated with increasing concentrations of bacDCN56(A), bacE162Q(B), bacE181K(C), bacE181Q(D), bacT184V(E), bacE193Q(F), bacY205F(G), bacR207S(H), bacD210N(I) , GST(J), Binding was determined by measuring the enzymatic activity of GST; protein concentration is plotted on a semi-log scale. Data represent the average of four independent measurements. Error bars represent SD. Binding was detected by anti-His antibody, followed by alkaline phosphatase-conjugated antibody and phosphatase substrate. Background (without decorins) was subtracted before plotting. Concentration of added ligand is plotted on a semi-log scale. Data represent the average of four independent measurements. Error bars represent SD. Fig.6 . Inhibition of collagen-decorin interaction by synthetic peptides. 96-well plastic plates were coated with acid-extracted collagen type I, incubated with mammalian-expressed decorin (A) or fibromodulin (B) and increasing concentrations of SYIRIADTNIT ( ) and SYISIANTNIT ( ). Bound decorin or fibromodulin were detected by anti-His antibody, followed by alkaline phosphataseconjugated antibody and phosphatase substrate. Background (without decorin or fibromodulin) was subtracted. Concentration of added ligand is plotted on a semi-log scale. Data represent the average of four independent measurements. Error bars represent SD. Fig. 7 . Collagen fibrillogenesis assay. Pepsin-extracted acid solubilized collagen was neutralized and incubated at 37 o C in the presence of decorin (A), mamR207S (B), mamD210N (C) and synthetic peptides (D). Decorin, mamR207S and mamD210N were present at 1 µg/ml ( ) and 2 µg/ml ( ).
Synthetic peptide SYIRIADTNIT at 10 µg/ml ( ) and 150 µg/ml ( ). Control peptide SYISIANTNIT at 150 µg/ml (X). Control with collagen alone ( ). Turbidity at 400 nm was measured continuously at 4 min intervals and plotted versus elapsed time. 
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